Social media

 

PANVIPREP has been actively featured across LinkedInFaceBook and other social media platforms or institutional pages. 
The project is consistently highlighted in terms of its partner roles, scientific goals, and its place within the broader landscape of pandemic preparedness.

 



Platform

~ Date

Source / Profile

Content Summary

Engagement / Notes

EU Newsletter

Dec 2023

IMI CARE Final Newsletter (PDF)

Officially announcement of PANVIPREP launch in January 2024 as CARE follow-up

Distributed to the EU research audience

Facebook

~2024

Laboratoř Strukturní chemie (Czech Academy of Sciences)

Local Czech-language post sharing PANVIPREP link for academic audience

Engagement is not shown publicly

LinkedIn

~Feb 2025

PANVIPREP / Helmholtz HZI

Member spotlight – chemical biology, PROTACs, PK/PD, role in antiviral discovery

~16 reactions

LinkedIn

~Mar 2025

Science / Business

Business (https://www.linkedin.com/posts/science-business_pandemic-preparedness-health-activity-7306018718013136896-RRn5)

Tagged PANVIPREP in a post about European pandemic preparedness

LinkedIn

~Apr 2025

IMI CARE

Mentions PANVIPREP as successor project; CARE wrap-up context

Posted by a major EU initiative

LinkedIn

~May 2025

PANVIPREP / Institute of Virology and Immunology (IVI)

Role in in vitro testing, animal model coordination, and reporter virus use

Modest engagement, post visible

ORCID

Active

Etienne Decroly ORCID Profile

Lists PANVIPREP under EU projects linked to virology & antiviral R&D

Professional CV entry

Develop-ment Aid

Ongoing

DevelopmentAid project page

Describes goals: 25–50 hit molecules, 2 early lead compounds to PoC, use of AI/structural tools

Indexed for funding/research access

Institutional Website

Ongoing

Helmholtz HZI PK/PD Unit

Notes PANVIPREP participation & team expertise in anti-infective preclinical research

Institutional-level visibility